Press "Enter" to skip to content

New patent for Alnylam Pharms drug OXLUMO

0
Copyright © DrugPatentWatch. Originally published at New patent for Alnylam Pharms drug OXLUMO

Annual Drug Patent Expirations for OXLUMO
Annual Drug Patent Expirations for OXLUMO

Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug.

This drug has one hundred and twenty-two patent family members in thirty-six countries.

The generic ingredient in OXLUMO is lumasiran sodium. Additional details are available on the lumasiran sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Alnylam Pharms drug OXLUMO
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions